Drug Trial Radar · NCT00003751
Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma
Last checked: Nov 20, 2026Latest source record: May 3, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Planned (sponsor's estimate)
Start
Mar 1999
Primary completion
Jun 2004
Study completion Jul 2005
Sponsor
- Lead sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Aug 18, 2004
Design
- Study type
- Interventional
- Phase
- Phase 2
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Penicillamine may stop the growth of glioblastomas by stopping blood flow to the tumor. A diet low in copper may interfere with the growth of brain tumor cells. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining these therapies may be effective in treating glioblastoma. PURPOSE: Phase II trial to study the effectiveness of penicillamine, a low copper diet, and radiation therapy in treating patients who have newly diagnosed glioblastoma.
Conditions
- Brain and Central Nervous System Tumors
Interventions
penicillamineDrug
radiation therapyRadiation
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama Comprehensive Cancer Center
Birmingham, Alabama
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida
Emory University School of Medicine
Atlanta, Georgia
Johns Hopkins Oncology Center
Baltimore, Maryland
Massachusetts General Hospital Cancer Center
Boston, Massachusetts
Henry Ford Hospital
Detroit, Michigan
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina
University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania
University of Texas Health Science Center at San Antonio
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.